Full Text
Cost-Effectiveness Analysis of Rivaroxaban in Secondary Prevention of ACS in Sweden

Abstract

Authors

N. Begum B. Van Hout S. Thurston O. Schoeman A. Fraschke F.W.A. Verheugt

Back to Volume 16, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×